Last price paid | 0.88 | |
Change | -3.30% [ -0.03 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 14.06.2024 17:20 |
Fixing | n.a. |
Settlement date | 13.02.2023 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +42.31% |
Year to date (YTD) | -25.42% |
1 month | -34.81% |
3 months | -27.87% |
1 year | +44.26% |
3 years | n.a. |
Issue price | 0.65 |
Underlying price on issue | 284.03 |
Premium | 0.00% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1237241786 |
Symbol | IROCTZ |
Security | 123724178 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Roche Hldg G, CH0012032048 |
Underlying ISIN | CH0012032048 |
Funding level | 290.827500 |
Stop-loss level | 282.261600 |
Distance to stop-loss level | 15.30% |
Long/Short type | Short |
Subscription ratio | 50.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 09.02.2023 |
Premium | 0.08% |
Premium p.a. | n.a. |
Leverage | 5.29 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 46.027500 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
UBS | 27.41 |
ABB Ltd | 50.30 |
Swiss Life Hldg | 636.80 |
Givaudan | 4'322.00 |
ZURICH INSURANCE | 473.70 |
Name | Price |
---|---|
Compagnie Financi... | 141.95 |
NOVARTIS N | 93.76 |
ROCHE GS | 244.80 |
Lonza Group | 476.00 |
Sika AG | 254.50 |